DAVID BEAR, MD
David Bear obtained a BA Summa cum Laude from Harvard College. Upon graduation, he was awarded a Sheldon Traveling Fellowship for study of Mind Body relationships. He attended Harvard Medical School, receiving an MD Magna cum Laude. Dr. Bear completed Psychiatric Residency at the Massachusetts General Hospital, subsequently receiving a Dupont Warren Fellowship.
Following a Fellowship at the National Institute of Neurologic Disease and Stroke, Bear became Psychiatric Director of the newly formed Behavioral Neurology Unit at Boston’s Beth Israel Hospital. There he initiated studies of the Neurology of Emotion with the late Norman Geschwind, a Founder of American Behavioral Neurology and the James Jackson Putnam Professor of Neurology at Harvard Medical School.
Based on his work on neurologic structure-function relationships in control of aggression, Bear was chosen as an Expert Witness in the trial of John Hinckley, where he first introduced Brain Imaging in Federal Court as evidence for an Insanity Defense.
After serving on the faculties of Harvard, Vanderbilt, and the University of Massachusetts Medical School where he was Professor of Psychiatry, Bear became a pioneer in Telepsychiatry. His experience led to the founding of 4 companies in the areas of Medication Adherence, Serialization of Unit Doses of Medication to Prevent Abuse, and Development of Novel Psychiatric Drugs.
Dr. Bear has received patents for devices to monitor medication use, an abuse resistant opioid, copy resistant serialized labels, pill tracking technology, and methods to prevent desensitization to dopamine agonists.